- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT01522976
Azacitidin s nebo bez lenalidomidu nebo vorinostatu při léčbě pacientů s myelodysplastickým syndromem s vyšším rizikem nebo chronickou myelomonocytární leukémií
Randomizovaná studie fáze II/III azacitidinu v kombinaci s lenalidomidem (NSC-703813) vs. azacitidin samotný vs. azacitidin v kombinaci s vorinostatem (NSC-701852) pro myelodysplastické syndromy s vyšším rizikem (MDS) a chronickou myelomonocytární leukemickou leukemii
This randomized phase II/III trial studies how well azacitidine works with or without lenalidomide or vorinostat in treating patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukemia. Drugs used in chemotherapy, such as azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, stopping them from dividing, or by stopping them from spreading. Lenalidomide may stop the growth of cancer cells by stopping blood flow to the cancer. Vorinostat may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. It is not yet known whether azacitidine is more effective with or without lenalidomide or vorinostat in treating myelodysplastic syndromes or chronic myelomonocytic leukemia.
Přehled studie
Postavení
Podmínky
Intervence / Léčba
Detailní popis
PRIMARY OBJECTIVES:
I. To select based on response rate (complete remission, partial remission, or hematologic improvement) either the combination of lenalidomide and azacitidine or the combination of vorinostat and azacitidine for further testing against single-agent azacitidine among patients with higher-risk myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). (Phase II) II. To compare overall survival between the combination arm selected in the Phase II portion of the trial to single-agent azacitidine among patients with higher-risk myelodysplastic syndromes (MDS) or chronic myelomonocytic leukemia (CMML). (Phase III)
SECONDARY OBJECTIVES:
I. To estimate relapse-free survival, overall survival and cytogenetic response rate of patients treated on each regimen.
II. To estimate the frequency and severity of toxicities of the three regimens in this patient population.
III. To investigate in a preliminary manner the frequency of subgroups from prestudy cytogenetic studies and correlate these subgroups with clinical outcomes in this patient population.
IV. To collect specimens for banking for use in future research studies.
TERTIARY OBJECTIVES:
I. To evaluate the prevalence of a pre-specified list of molecular lesions (48 total lesions).
II. To assess associations of these lesions with outcomes (response, event-free survival, relapse-free survival, and overall survival).
III. To develop a deoxyribonucleic acid (DNA) methylation biomarker predictive of response to DMTi treatment in MDS.
IV. To harness gene expression profiles as clinical biomarkers of primary resistance to DMTi in MDS.
OUTLINE: Patients are randomized to 1 of 3 treatment arms. In Phase III, patients are randomized to 1 of 2 treatment arms (the combination arm selected in Phase II or the single-agent azacitidine arm).
ARM I: Patients receive azacitidine subcutaneously (SC) or intravenously (IV) on days 1-7 or days 1-5 and 8-9, and lenalidomide orally (PO) once daily (QD) on days 1-21.
ARM II: Patients receive azacitidine as in Arm I.
ARM III: Patients receive azacitidine as in Arm I and vorinostat PO twice daily (BID) on days 3-9.
In all arms, treatment repeats every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up every 3 months for up to 5 years.
Typ studie
Zápis (Aktuální)
Fáze
- Fáze 2
Kontakty a umístění
Studijní místa
-
-
Alberta
-
Calgary, Alberta, Kanada, T2N 5G2
- Arthur J E Child Comprehensive Cancer Centre
-
-
British Columbia
-
Vancouver, British Columbia, Kanada, V5Z 3P1
- Clinical Research Unit at Vancouver Coastal Health Authority
-
-
Manitoba
-
Winnipeg, Manitoba, Kanada, R3E 0V9
- CancerCare Manitoba
-
-
New Brunswick
-
Moncton, New Brunswick, Kanada, E1C 6Z8
- The Moncton Hospital
-
Saint John, New Brunswick, Kanada, E2L 4L2
- Atlantic Health Sciences Corporation-Saint John Regional Hospital
-
-
Nova Scotia
-
Halifax, Nova Scotia, Kanada, B3H 2Y9
- QEII Health Sciences Centre/Nova Scotia Health Authority
-
-
Ontario
-
Hamilton, Ontario, Kanada, L8V 5C2
- Juravinski Cancer Centre at Hamilton Health Sciences
-
Toronto, Ontario, Kanada, M5G 2M9
- University Health Network-Princess Margaret Hospital
-
Toronto, Ontario, Kanada, M4N 3M5
- Odette Cancer Centre- Sunnybrook Health Sciences Centre
-
-
Quebec
-
Greenfield Park, Quebec, Kanada, J4V 2H1
- CSSS Champlain-Charles Le Moyne
-
Montreal, Quebec, Kanada, H3H 2R9
- The Research Institute of the McGill University Health Centre (MUHC)
-
Montreal, Quebec, Kanada, H2W 1S6
- McGill University Department of Oncology
-
-
Saskatchewan
-
Regina, Saskatchewan, Kanada, S4T 7T1
- Allan Blair Cancer Centre
-
Saskatoon, Saskatchewan, Kanada, S7N 4H4
- Saskatoon Cancer Centre
-
-
-
-
Alabama
-
Birmingham, Alabama, Spojené státy, 35233
- University of Alabama at Birmingham Cancer Center
-
Mobile, Alabama, Spojené státy, 36688
- University of South Alabama Mitchell Cancer Institute
-
-
Arizona
-
Scottsdale, Arizona, Spojené státy, 85259
- Mayo Clinic in Arizona
-
Tucson, Arizona, Spojené státy, 85719
- Banner University Medical Center - Tucson
-
Tucson, Arizona, Spojené státy, 85719
- University of Arizona Cancer Center-North Campus
-
-
Arkansas
-
Little Rock, Arkansas, Spojené státy, 72205
- John L McClellan Memorial Veterans Hospital
-
-
California
-
Antioch, California, Spojené státy, 94531
- Kaiser Permanente-Deer Valley Medical Center
-
Duarte, California, Spojené státy, 91010
- City of Hope Comprehensive Cancer Center
-
Los Angeles, California, Spojené státy, 90033
- USC / Norris Comprehensive Cancer Center
-
Oakland, California, Spojené státy, 94611
- Kaiser Permanente-Oakland
-
Palo Alto, California, Spojené státy, 94304
- Stanford Cancer Institute Palo Alto
-
Richmond, California, Spojené státy, 94801
- Kaiser Permanente-Richmond
-
Sacramento, California, Spojené státy, 95823
- Kaiser Permanente-South Sacramento
-
Sacramento, California, Spojené státy, 95825
- Kaiser Permanente Sacramento Medical Center
-
San Francisco, California, Spojené státy, 94115
- Kaiser Permanente-San Francisco
-
San Jose, California, Spojené státy, 95119
- Kaiser Permanente-Santa Teresa-San Jose
-
San Rafael, California, Spojené státy, 94903
- Kaiser Permanente-San Rafael
-
Santa Clara, California, Spojené státy, 95051
- Kaiser Permanente Medical Center - Santa Clara
-
Santa Rosa, California, Spojené státy, 95403
- Kaiser Permanente-Santa Rosa
-
Santa Rosa, California, Spojené státy, 95403
- Sutter Pacific Medical Foundation
-
South San Francisco, California, Spojené státy, 94080
- Kaiser Permanente-South San Francisco
-
Vallejo, California, Spojené státy, 94589
- Kaiser Permanente-Vallejo
-
Walnut Creek, California, Spojené státy, 94596
- Kaiser Permanente-Walnut Creek
-
-
Colorado
-
Aurora, Colorado, Spojené státy, 80012
- The Medical Center of Aurora
-
Aurora, Colorado, Spojené státy, 80045
- UCHealth University of Colorado Hospital
-
Boulder, Colorado, Spojené státy, 80303
- Boulder Community Foothills Hospital
-
Colorado Springs, Colorado, Spojené státy, 80907
- Penrose-Saint Francis Healthcare
-
Denver, Colorado, Spojené státy, 80218
- Presbyterian - Saint Lukes Medical Center - Health One
-
Denver, Colorado, Spojené státy, 80220
- Rose Medical Center
-
Denver, Colorado, Spojené státy, 80218
- Rocky Mountain Cancer Centers-Midtown
-
Denver, Colorado, Spojené státy, 80220
- Rocky Mountain Cancer Centers-Rose
-
Denver, Colorado, Spojené státy, 80218
- Colorado Blood Cancer Institute
-
Denver, Colorado, Spojené státy, 80222
- Western States Cancer Research NCORP
-
Denver, Colorado, Spojené státy, 80218
- Saint Joseph Hospital - Cancer Centers of Colorado
-
Denver, Colorado, Spojené státy, 80210
- AdventHealth Porter
-
Durango, Colorado, Spojené státy, 81301
- Mercy Medical Center
-
Englewood, Colorado, Spojené státy, 80113
- Mountain Blue Cancer Care Center - Swedish
-
Englewood, Colorado, Spojené státy, 80113
- Swedish Medical Center
-
Fort Collins, Colorado, Spojené státy, 80524
- Poudre Valley Hospital
-
Golden, Colorado, Spojené státy, 80401
- Mountain Blue Cancer Care Center
-
Greeley, Colorado, Spojené státy, 80631
- Banner North Colorado Medical Center
-
Greenwood Village, Colorado, Spojené státy, 80111
- Rocky Mountain Cancer Centers-Greenwood Village
-
Lakewood, Colorado, Spojené státy, 80228
- Rocky Mountain Cancer Centers-Lakewood
-
Lakewood, Colorado, Spojené státy, 80228
- CommonSpirit Saint Anthony Hospital Cancer Center
-
Littleton, Colorado, Spojené státy, 80122
- AdventHealth Littleton
-
Lone Tree, Colorado, Spojené státy, 80124
- Sky Ridge Medical Center
-
Lone Tree, Colorado, Spojené státy, 80124
- Rocky Mountain Cancer Centers-Sky Ridge
-
Longmont, Colorado, Spojené státy, 80501
- Longmont United Hospital
-
Loveland, Colorado, Spojené státy, 80539
- Banner North Colorado Medical Center - Loveland Campus
-
Parker, Colorado, Spojené státy, 80138
- Rocky Mountain Cancer Centers-Parker
-
Parker, Colorado, Spojené státy, 80138
- AdventHealth Parker
-
Pueblo, Colorado, Spojené státy, 81004
- Saint Mary Corwin Medical Center
-
Wheat Ridge, Colorado, Spojené státy, 80401
- Intermountain Health Lutheran Hospital
-
-
Connecticut
-
Farmington, Connecticut, Spojené státy, 06030
- University of Connecticut
-
Hartford, Connecticut, Spojené státy, 06105
- Smilow Cancer Hospital Care Center at Saint Francis
-
New Britain, Connecticut, Spojené státy, 06050
- The Hospital of Central Connecticut
-
-
Delaware
-
Lewes, Delaware, Spojené státy, 19958
- Beebe Medical Center
-
Newark, Delaware, Spojené státy, 19718
- Christiana Care Health System-Christiana Hospital
-
-
District of Columbia
-
Washington D.C., District of Columbia, Spojené státy, 20016
- Sibley Memorial Hospital
-
Washington D.C., District of Columbia, Spojené státy, 20422
- Veterans Affairs Medical Center -Washington DC
-
-
Florida
-
Gainesville, Florida, Spojené státy, 32610
- UF Health Cancer Institute - Gainesville
-
Jupiter, Florida, Spojené státy, 33458
- Jupiter Medical Center
-
Miami Beach, Florida, Spojené státy, 33140
- Mount Sinai Medical Center
-
Orlando, Florida, Spojené státy, 32803
- AdventHealth Orlando
-
-
Georgia
-
Augusta, Georgia, Spojené státy, 30912
- Augusta University Medical Center
-
-
Hawaii
-
Honolulu, Hawaii, Spojené státy, 96813
- Hawaii Cancer Care Inc - Waterfront Plaza
-
Honolulu, Hawaii, Spojené státy, 96813
- Straub Clinic and Hospital
-
Honolulu, Hawaii, Spojené státy, 96813
- University of Hawaii Cancer Center
-
Honolulu, Hawaii, Spojené státy, 96817
- Queen's Cancer Center - Kuakini
-
Honolulu, Hawaii, Spojené státy, 96819
- Kaiser Permanente Moanalua Medical Center
-
-
Idaho
-
Boise, Idaho, Spojené státy, 83706
- Saint Alphonsus Cancer Care Center-Boise
-
Post Falls, Idaho, Spojené státy, 83854
- Kootenai Clinic Cancer Services - Post Falls
-
-
Illinois
-
Bloomington, Illinois, Spojené státy, 61704
- Illinois CancerCare-Bloomington
-
Canton, Illinois, Spojené státy, 61520
- Illinois CancerCare-Canton
-
Carthage, Illinois, Spojené státy, 62321
- Illinois CancerCare-Carthage
-
Chicago, Illinois, Spojené státy, 60611
- Northwestern University
-
Chicago, Illinois, Spojené státy, 60637
- University of Chicago Comprehensive Cancer Center
-
Chicago, Illinois, Spojené státy, 60612
- University of Illinois
-
Chicago, Illinois, Spojené státy, 60611
- Hematology and Oncology Associates
-
Decatur, Illinois, Spojené státy, 62526
- Decatur Memorial Hospital
-
Decatur, Illinois, Spojené státy, 62526
- Heartland Cancer Research NCORP
-
Eureka, Illinois, Spojené státy, 61530
- Illinois CancerCare-Eureka
-
Evanston, Illinois, Spojené státy, 60201
- NorthShore University HealthSystem-Evanston Hospital
-
Galesburg, Illinois, Spojené státy, 61401
- Illinois CancerCare-Galesburg
-
Havana, Illinois, Spojené státy, 62644
- Illinois CancerCare-Havana
-
Kewanee, Illinois, Spojené státy, 61443
- Illinois CancerCare-Kewanee Clinic
-
Macomb, Illinois, Spojené státy, 61455
- Illinois CancerCare-Macomb
-
Maywood, Illinois, Spojené státy, 60153
- Loyola University Medical Center
-
Moline, Illinois, Spojené státy, 61265
- Trinity Medical Center
-
Monmouth, Illinois, Spojené státy, 61462
- Illinois CancerCare-Monmouth
-
Normal, Illinois, Spojené státy, 61761
- Illinois CancerCare-Community Cancer Center
-
Ottawa, Illinois, Spojené státy, 61350
- Illinois CancerCare-Ottawa Clinic
-
Pekin, Illinois, Spojené státy, 61554
- Illinois CancerCare-Pekin
-
Peoria, Illinois, Spojené státy, 61615
- Illinois CancerCare-Peoria
-
Peru, Illinois, Spojené státy, 61354
- Illinois CancerCare-Peru
-
Princeton, Illinois, Spojené státy, 61356
- Illinois CancerCare-Princeton
-
Rockford, Illinois, Spojené státy, 61104
- Swedish American Hospital
-
Rockford, Illinois, Spojené státy, 61114
- UW Health Carbone Cancer Center Rockford
-
Springfield, Illinois, Spojené státy, 62781
- Springfield Memorial Hospital
-
Urbana, Illinois, Spojené státy, 61801
- Carle Cancer Center
-
-
Indiana
-
Merrillville, Indiana, Spojené státy, 46410
- Premier Oncology Hematology Associates
-
-
Iowa
-
Ames, Iowa, Spojené státy, 50010
- McFarland Clinic - Ames
-
Iowa City, Iowa, Spojené státy, 52242
- University of Iowa/Holden Comprehensive Cancer Center
-
Sioux City, Iowa, Spojené státy, 51101
- Siouxland Regional Cancer Center
-
Waterloo, Iowa, Spojené státy, 50702
- MercyOne Waterloo Cancer Center
-
-
Kansas
-
Kansas City, Kansas, Spojené státy, 66160
- University of Kansas Cancer Center
-
Prairie Village, Kansas, Spojené státy, 66208
- Kansas City NCI Community Oncology Research Program
-
Topeka, Kansas, Spojené státy, 66606
- Cotton O'Neil Cancer Center / Stormont Vail Health
-
-
Kentucky
-
Lexington, Kentucky, Spojené státy, 40536
- University of Kentucky/Markey Cancer Center
-
-
Louisiana
-
Baton Rouge, Louisiana, Spojené státy, 70809
- Ochsner Health Center-Summa
-
New Orleans, Louisiana, Spojené státy, 70121
- Ochsner Medical Center Jefferson
-
Shreveport, Louisiana, Spojené státy, 71103
- LSU Health Sciences Center at Shreveport
-
-
Maine
-
Bangor, Maine, Spojené státy, 04401
- Eastern Maine Medical Center
-
-
Maryland
-
Baltimore, Maryland, Spojené státy, 21287
- Johns Hopkins University/Sidney Kimmel Cancer Center
-
Elkton, Maryland, Spojené státy, 21921
- Christiana Care - Union Hospital
-
-
Massachusetts
-
Boston, Massachusetts, Spojené státy, 02215
- Dana-Farber Cancer Institute
-
Boston, Massachusetts, Spojené státy, 02114
- Massachusetts General Hospital Cancer Center
-
Brighton, Massachusetts, Spojené státy, 02135
- Dana-Farber Cancer Institute at Boston Medical Center - Brighton
-
Springfield, Massachusetts, Spojené státy, 01199
- Baystate Medical Center
-
Worcester, Massachusetts, Spojené státy, 01655
- UMass Memorial Medical Center - University Campus
-
-
Michigan
-
Ann Arbor, Michigan, Spojené státy, 48106
- Michigan Cancer Research Consortium NCORP
-
Ann Arbor, Michigan, Spojené státy, 48106
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor
-
Battle Creek, Michigan, Spojené státy, 49017
- Bronson Battle Creek
-
Detroit, Michigan, Spojené státy, 48201
- Wayne State University/Karmanos Cancer Institute
-
Detroit, Michigan, Spojené státy, 48236
- Henry Ford Health Saint John Hospital
-
Escanaba, Michigan, Spojené státy, 49829
- OSF Saint Francis Hospital and Medical Group
-
Grand Rapids, Michigan, Spojené státy, 49503
- Cancer Research Consortium of West Michigan NCORP
-
Grand Rapids, Michigan, Spojené státy, 49503
- Trinity Health Grand Rapids Hospital
-
Grand Rapids, Michigan, Spojené státy, 49503
- Corewell Health Grand Rapids Hospitals - Butterworth Hospital
-
Kalamazoo, Michigan, Spojené státy, 49007
- West Michigan Cancer Center
-
Muskegon, Michigan, Spojené státy, 49444
- Trinity Health Muskegon Hospital
-
Port Huron, Michigan, Spojené státy, 48060
- Lake Huron Medical Center
-
Reed City, Michigan, Spojené státy, 49677
- Corewell Health Reed City Hospital
-
Traverse City, Michigan, Spojené státy, 49684
- Munson Medical Center
-
Warren, Michigan, Spojené státy, 48093
- Henry Ford Health Warren Hospital
-
-
Minnesota
-
Bemidji, Minnesota, Spojené státy, 56601
- Sanford Joe Lueken Cancer Center
-
Burnsville, Minnesota, Spojené státy, 55337
- Fairview Ridges Hospital
-
Coon Rapids, Minnesota, Spojené státy, 55433
- Mercy Hospital
-
Duluth, Minnesota, Spojené státy, 55805
- Essentia Health Cancer Center
-
Edina, Minnesota, Spojené státy, 55435
- Fairview Southdale Hospital
-
Fridley, Minnesota, Spojené státy, 55432
- Unity Hospital
-
Hutchinson, Minnesota, Spojené státy, 55350
- Hutchinson Area Health Care
-
Maplewood, Minnesota, Spojené státy, 55109
- Saint John's Hospital - Healtheast
-
Maplewood, Minnesota, Spojené státy, 55109
- Minnesota Oncology Hematology PA-Maplewood
-
Minneapolis, Minnesota, Spojené státy, 55415
- Hennepin County Medical Center
-
Minneapolis, Minnesota, Spojené státy, 55407
- Abbott-Northwestern Hospital
-
Minneapolis, Minnesota, Spojené státy, 55417
- Minneapolis VA Medical Center
-
Robbinsdale, Minnesota, Spojené státy, 55422
- North Memorial Medical Health Center
-
Rochester, Minnesota, Spojené státy, 55905
- Mayo Clinic in Rochester
-
Saint Cloud, Minnesota, Spojené státy, 56303
- Coborn Cancer Center at Saint Cloud Hospital
-
Saint Louis Park, Minnesota, Spojené státy, 55416
- Park Nicollet Clinic - Saint Louis Park
-
Saint Louis Park, Minnesota, Spojené státy, 55416
- Metro Minnesota Community Oncology Research Consortium
-
Saint Paul, Minnesota, Spojené státy, 55101
- Regions Hospital
-
Saint Paul, Minnesota, Spojené státy, 55102
- United Hospital
-
Shakopee, Minnesota, Spojené státy, 55379
- Saint Francis Regional Medical Center
-
Stillwater, Minnesota, Spojené státy, 55082
- Lakeview Hospital
-
Waconia, Minnesota, Spojené státy, 55387
- Ridgeview Medical Center
-
Willmar, Minnesota, Spojené státy, 56201
- Rice Memorial Hospital
-
Woodbury, Minnesota, Spojené státy, 55125
- Minnesota Oncology Hematology PA-Woodbury
-
-
Mississippi
-
Jackson, Mississippi, Spojené státy, 39216
- University of Mississippi Medical Center
-
-
Missouri
-
Cape Girardeau, Missouri, Spojené státy, 63703
- Saint Francis Medical Center
-
Columbia, Missouri, Spojené státy, 65201
- Veterans Administration
-
Columbia, Missouri, Spojené státy, 65212
- MU Health - University Hospital/Ellis Fischel Cancer Center
-
Kansas City, Missouri, Spojené státy, 64111
- Saint Luke's Hospital of Kansas City
-
St Louis, Missouri, Spojené státy, 63141
- Mercy Hospital Saint Louis
-
St Louis, Missouri, Spojené státy, 63141
- Saint Louis-Cape Girardeau CCOP
-
-
Montana
-
Billings, Montana, Spojené státy, 59101
- Billings Clinic Cancer Center
-
Bozeman, Montana, Spojené státy, 59715
- Bozeman Health Deaconess Hospital
-
-
New Jersey
-
Camden, New Jersey, Spojené státy, 08103
- Cooper Hospital University Medical Center
-
-
New Mexico
-
Albuquerque, New Mexico, Spojené státy, 87106
- University of New Mexico Cancer Center
-
Albuquerque, New Mexico, Spojené státy, 87110
- Presbyterian Kaseman Hospital
-
-
New York
-
Buffalo, New York, Spojené státy, 14263
- Roswell Park Cancer Institute
-
Lake Success, New York, Spojené státy, 11042
- Northwell Health/Center for Advanced Medicine
-
Manhasset, New York, Spojené státy, 11030
- North Shore University Hospital
-
Mineola, New York, Spojené státy, 11501
- NYU Langone Hospital - Long Island
-
New York, New York, Spojené státy, 10065
- NYP/Weill Cornell Medical Center
-
Rochester, New York, Spojené státy, 14642
- University of Rochester
-
The Bronx, New York, Spojené státy, 10467
- Montefiore Medical Center - Moses Campus
-
The Bronx, New York, Spojené státy, 10461
- Montefiore Medical Center-Weiler Hospital
-
-
North Carolina
-
Asheboro, North Carolina, Spojené státy, 27203
- Randolph Hospital
-
Goldsboro, North Carolina, Spojené státy, 27534
- Wayne Memorial Hospital
-
Greensboro, North Carolina, Spojené státy, 27403
- Cone Health Cancer Center
-
Hendersonville, North Carolina, Spojené státy, 28791
- Margaret R Pardee Memorial Hospital
-
Kinston, North Carolina, Spojené státy, 28501
- ECU Health Oncology Kinston
-
Pinehurst, North Carolina, Spojené státy, 28374
- FirstHealth of the Carolinas-Moore Regional Hospital
-
Reidsville, North Carolina, Spojené státy, 27320
- Annie Penn Memorial Hospital
-
Statesville, North Carolina, Spojené státy, 28677
- Iredell Memorial Hospital
-
Winston-Salem, North Carolina, Spojené státy, 27104
- Southeast Clinical Oncology Research Consortium NCORP
-
-
North Dakota
-
Bismarck, North Dakota, Spojené státy, 58501
- Sanford Bismarck Medical Center
-
Bismarck, North Dakota, Spojené státy, 58501
- Mid Dakota Clinic
-
Fargo, North Dakota, Spojené státy, 58122
- Sanford Roger Maris Cancer Center
-
Fargo, North Dakota, Spojené státy, 58122
- Sanford Broadway Medical Center
-
-
Ohio
-
Beachwood, Ohio, Spojené státy, 44122
- Cleveland Clinic Cancer Center Beachwood
-
Cincinnati, Ohio, Spojené státy, 45219
- University of Cincinnati Cancer Center-UC Medical Center
-
Cleveland, Ohio, Spojené státy, 44106
- Case Western Reserve University
-
Cleveland, Ohio, Spojené státy, 44195
- Cleveland Clinic Foundation
-
Cleveland, Ohio, Spojené státy, 44111
- Cleveland Clinic Cancer Center/Fairview Hospital
-
Columbus, Ohio, Spojené státy, 43214
- Riverside Methodist Hospital
-
Columbus, Ohio, Spojené státy, 43219
- The Mark H Zangmeister Center
-
Columbus, Ohio, Spojené státy, 43222
- Mount Carmel Health Center West
-
Columbus, Ohio, Spojené státy, 43215
- Columbus NCI Community Oncology Research Program
-
Dayton, Ohio, Spojené státy, 45409
- Miami Valley Hospital
-
Independence, Ohio, Spojené státy, 44131
- Cleveland Clinic Cancer Center Independence
-
Marietta, Ohio, Spojené státy, 45750
- Marietta Memorial Hospital
-
Mayfield Heights, Ohio, Spojené státy, 44124
- Hillcrest Hospital Cancer Center
-
Newark, Ohio, Spojené státy, 43055
- Licking Memorial Hospital
-
Parma, Ohio, Spojené státy, 44129
- University Hospitals Parma Medical Center
-
Sandusky, Ohio, Spojené státy, 44870
- North Coast Cancer Care
-
Springfield, Ohio, Spojené státy, 45504
- Springfield Regional Medical Center
-
Strongsville, Ohio, Spojené státy, 44136
- Cleveland Clinic Cancer Center Strongsville
-
Sylvania, Ohio, Spojené státy, 43560
- ProMedica Flower Hospital
-
Toledo, Ohio, Spojené státy, 43614
- University of Toledo
-
Westerville, Ohio, Spojené státy, 43081
- Saint Ann's Hospital
-
Wooster, Ohio, Spojené státy, 44691
- Cleveland Clinic Wooster Family Health and Surgery Center
-
-
Oklahoma
-
Norman, Oklahoma, Spojené státy, 73071
- Cancer Care Associates-Norman
-
Oklahoma City, Oklahoma, Spojené státy, 73104
- University of Oklahoma Health Sciences Center
-
Oklahoma City, Oklahoma, Spojené státy, 73120
- Mercy Hospital Oklahoma City
-
-
Oregon
-
Gresham, Oregon, Spojené státy, 97030
- Legacy Mount Hood Medical Center
-
Milwaukie, Oregon, Spojené státy, 97222
- Providence Milwaukie Hospital
-
Newberg, Oregon, Spojené státy, 97132
- Providence Newberg Medical Center
-
Oregon City, Oregon, Spojené státy, 97045
- Providence Willamette Falls Medical Center
-
Portland, Oregon, Spojené státy, 97210
- Legacy Good Samaritan Hospital and Medical Center
-
Portland, Oregon, Spojené státy, 97213
- Providence Portland Medical Center
-
Portland, Oregon, Spojené státy, 97225
- Providence Saint Vincent Medical Center
-
-
Pennsylvania
-
Allentown, Pennsylvania, Spojené státy, 18103
- Lehigh Valley Hospital-Cedar Crest
-
Carlisle, Pennsylvania, Spojené státy, 17015
- Carlisle Regional Cancer Center
-
Danville, Pennsylvania, Spojené státy, 17822
- Geisinger Medical Center
-
Doylestown, Pennsylvania, Spojené státy, 18901
- Doylestown Hospital
-
Hazleton, Pennsylvania, Spojené státy, 18201
- Geisinger Medical Center-Cancer Center Hazleton
-
Hershey, Pennsylvania, Spojené státy, 17033-0850
- Penn State Milton S Hershey Medical Center
-
Pittsburgh, Pennsylvania, Spojené státy, 15232
- UPMC Hillman Cancer Center
-
Sayre, Pennsylvania, Spojené státy, 18840
- Guthrie Medical Group PC-Robert Packer Hospital
-
West Reading, Pennsylvania, Spojené státy, 19611
- Reading Hospital
-
Wilkes-Barre, Pennsylvania, Spojené státy, 18711
- Geisinger Wyoming Valley/Henry Cancer Center
-
-
South Carolina
-
Boiling Springs, South Carolina, Spojené státy, 29316
- Prisma Health Cancer Institute - Spartanburg
-
Charleston, South Carolina, Spojené státy, 29401
- Roper Hospital
-
Greenville, South Carolina, Spojené státy, 29605
- Prisma Health Cancer Institute - Faris
-
Greenville, South Carolina, Spojené státy, 29615
- Prisma Health Cancer Institute - Eastside
-
Greenville, South Carolina, Spojené státy, 29605
- Prisma Health Cancer Institute - Butternut
-
Greenville, South Carolina, Spojené státy, 29601
- Saint Francis Hospital
-
Greenville, South Carolina, Spojené státy, 29605
- Prisma Health Greenville Memorial Hospital
-
Seneca, South Carolina, Spojené státy, 29672
- Prisma Health Cancer Institute - Seneca
-
Spartanburg, South Carolina, Spojené státy, 29303
- Spartanburg Medical Center
-
-
South Dakota
-
Rapid City, South Dakota, Spojené státy, 57701
- Rapid City Regional Hospital
-
Sioux Falls, South Dakota, Spojené státy, 57117-5134
- Sanford USD Medical Center - Sioux Falls
-
Sioux Falls, South Dakota, Spojené státy, 57104
- Sanford Cancer Center Oncology Clinic
-
-
Tennessee
-
Knoxville, Tennessee, Spojené státy, 37916
- Covenant Health Cancer Centers
-
Nashville, Tennessee, Spojené státy, 37232
- Vanderbilt University/Ingram Cancer Center
-
-
Texas
-
Amarillo, Texas, Spojené státy, 79106
- The Don and Sybil Harrington Cancer Center
-
Dallas, Texas, Spojené státy, 75390
- UT Southwestern/Simmons Cancer Center-Dallas
-
-
Utah
-
Salt Lake City, Utah, Spojené státy, 84112
- Huntsman Cancer Institute/University of Utah
-
-
Virginia
-
Martinsville, Virginia, Spojené státy, 24112
- Sovah Health Martinsville
-
-
Washington
-
Vancouver, Washington, Spojené státy, 98664
- PeaceHealth Southwest Medical Center
-
-
West Virginia
-
Morgantown, West Virginia, Spojené státy, 26506
- West Virginia University Healthcare
-
-
Wisconsin
-
Chippewa Falls, Wisconsin, Spojené státy, 54729
- Marshfield Clinic-Chippewa Center
-
Eau Claire, Wisconsin, Spojené státy, 54701
- HSHS Sacred Heart Hospital
-
Eau Claire, Wisconsin, Spojené státy, 54701
- Marshfield Clinic Cancer Center at Sacred Heart
-
Green Bay, Wisconsin, Spojené státy, 54311
- Aurora BayCare Medical Center
-
Green Bay, Wisconsin, Spojené státy, 54301
- Saint Vincent Hospital Cancer Center Green Bay
-
Green Bay, Wisconsin, Spojené státy, 54303
- Saint Vincent Hospital Cancer Center at Saint Mary's
-
Green Bay, Wisconsin, Spojené státy, 54301-3526
- Green Bay Oncology at Saint Vincent Hospital
-
Janesville, Wisconsin, Spojené státy, 53548
- Mercyhealth Hospital and Cancer Center - Janesville
-
La Crosse, Wisconsin, Spojené státy, 54601
- Gundersen Lutheran Medical Center
-
Madison, Wisconsin, Spojené státy, 53715
- SSM Health Dean Medical Group - South Madison Campus
-
Marinette, Wisconsin, Spojené státy, 54143
- Aurora Bay Area Medical Group-Marinette
-
Marinette, Wisconsin, Spojené státy, 54143
- Bay Area Medical Center
-
Marshfield, Wisconsin, Spojené státy, 54449
- Marshfield Medical Center-Marshfield
-
Marshfield, Wisconsin, Spojené státy, 54449
- Marshfield Medical Center
-
Milwaukee, Wisconsin, Spojené státy, 53226
- Medical College of Wisconsin
-
Minocqua, Wisconsin, Spojené státy, 54548
- Marshfield Medical Center - Minocqua
-
Oconomowoc, Wisconsin, Spojené státy, 53066
- ProHealth Oconomowoc Memorial Hospital
-
Oconto Falls, Wisconsin, Spojené státy, 54154
- Saint Vincent Hospital Cancer Center at Oconto Falls
-
Rhinelander, Wisconsin, Spojené státy, 54501
- Aspirus Cancer Care-Rhinelander-James Beck Cancer Center
-
Rice Lake, Wisconsin, Spojené státy, 54868
- Marshfield Medical Center-Rice Lake
-
Stevens Point, Wisconsin, Spojené státy, 54481
- Aspirus Cancer Care - Stevens Point
-
Summit, Wisconsin, Spojené státy, 53066
- Aurora Medical Center in Summit
-
Waukesha, Wisconsin, Spojené státy, 53188
- ProHealth Waukesha Memorial Hospital
-
Wauwatosa, Wisconsin, Spojené státy, 53226
- Aurora Cancer Care-Milwaukee West
-
Weston, Wisconsin, Spojené státy, 54476
- Marshfield Medical Center - Weston
-
Wisconsin Rapids, Wisconsin, Spojené státy, 54494
- Marshfield Clinic - Wisconsin Rapids Center
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Popis
Inclusion Criteria:
-
Patients must have morphologically confirmed diagnosis of myelodysplastic syndrome (MDS) or chronic myelomonocytic leukemia (CMML) based on one of the following:
-
French-American-British (FAB) classifications:
- Refractory anemia with excess blasts (RAEB - defined as having 5-20% myeloblasts in the bone marrow)
- Chronic myelomonocytic leukemia (CMML) with 10-19% myeloblasts in the bone marrow and/or 5-19% blasts in the blood
-
World Health Organization (WHO) classifications:
- Refractory anemia with excess blasts-1 (RAEB-1 - defined as having 5-9% myeloblasts in the bone marrow)
- Refractory anemia with excess blasts-2 (RAEB-2 - defined as having 10-19% myeloblasts in the bone marrow and/or 5-19% blasts in the blood)
- Chronic myelomonocytic leukemia-1 (CMML-1 - defined as having < 10% myeloblasts in the bone marrow and/or < 5% blasts in the blood)
- Chronic myelomonocytic leukemia-2 (CMML-2 - defined as having 10-19% myeloblasts in the bone marrow and/or 5-19% blasts in the blood) OR
-
International prognostic score (IPSS) of intermediate 2 (1.5-2.0 points) or high (>= 2.5 points); a score of intermediate 1 (0.5-1.0 points) is only allowable in the setting of >= 5% myeloblasts
-
NOTE: Patients with acute myeloid leukemia (AML) are not eligible
-
Procedures to obtain specimens for establishing baseline disease must be done within 30 days prior to registration
-
-
Patients must not have received lenalidomide, azacitidine, vorinostat, or decitabine as treatment previously; any hematopoietic growth factors must be stopped for at least 14 days prior to registration; patients may have received low-dose cytarabine for MDS treatment previously, but they must have discontinued its use for at least 28 days prior to registration; patients may have received prior hydroxyurea per CMML treatment previously, but they must have discontinued its use for at least 7 days prior to registration; these patients will not be eligible if white blood cell (WBC) > 30,000/mm^3
-
Patients must not have received radiation therapy, chemotherapy, or cytotoxic therapy to treat conditions other than MDS within 12 months prior to registration
-
Patients must not have undergone prior allogeneic stem cell or bone marrow transplantation at any time; patients that have undergone an autologous stem cell transplant are eligible
-
Patients must not have used or be using histone deacetylase (HDAC) inhibitor agents for anticancer treatment
-
Patients may not have received agents such as valproic acid for epilepsy within 30 days prior to registration
-
Patients must have Zubrod performance status of 0-2
-
Patients must not have any pre-existing neurotoxicity/neuropathy of >= grade 2 according to the National Cancer Institute (NCI) Common Toxicity Criteria version 4.0, or prior >= grade 3 allergic reaction/hypersensitivity or rash to thalidomide, that has not resolved to < grade 2
-
Patients must not have any serious medical condition, laboratory abnormality, or psychiatric illness that, in the view of the treating physician, would place the participant at an unacceptable risk if he or she were to participate in the study or would prevent that person from giving informed consent
-
Patients must not have history of thromboembolic event or other condition requiring current use of anticoagulation with Coumadin (warfarin) or low molecular-weight heparin
-
Patients must not have known or suspected hypersensitivity to mannitol
-
Patients must receive a 12-lead electrocardiogram (EKG), chest x-ray or computed tomography (CT) scan, serum creatinine, complete metabolic panel including serum glutamic oxaloacetic transaminase (SGOT) or serum glutamate pyruvate transaminase (SGPT), electrolytes, and bilirubin testing within 28 days prior to registration in order to establish baseline measurements; questions regarding patient safety in regards to results of these tests should be directed to the study chair
-
Females of childbearing potential (FCBP) must have a negative serum or urine pregnancy test with a sensitivity of at least 25 mIU/mL within 10 - 14 days prior to registration; FCBP must agree to have a second pregnancy test within 24 hours prior to starting cycle 1 if randomized to receive lenalidomide
- Further, patients commit to the following if they are randomized to receive lenalidomide: FCBP must either commit to continued abstinence from heterosexual intercourse or begin TWO acceptable methods of birth control: one highly effective method and one additional effective method AT THE SAME TIME, at least 28 days before starting lenalidomide; FCBP must also agree to ongoing pregnancy testing; men must agree to use a latex condom during sexual contact with a FCBP, even if they have had a successful vasectomy; a FCBP is a sexually mature woman who: 1) has not undergone a hysterectomy or bilateral oophorectomy; or 2) has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months); all patients must be counseled by a trained counselor every 28 days about pregnancy precautions and risks of fetal exposure
- NOTE: Patients not randomized to receive lenalidomide will not be required to undergo serial pregnancy testing or lenalidomide counseling after registration
-
No prior malignancy is allowed except for adequately treated basal cell (or squamous cell) skin cancer, in situ cervical cancer, or other cancer for which the patient has been disease-free for three years
-
Cytogenetics requirements:
- Southwestern Oncology Group (SWOG) (and other sites not affiliated with Alliance or Eastern Cooperative Oncology Group [ECOG]-American College of Radiology Imaging Network [ACRIN]): Pretreatment cytogenetics must be performed on all patients; collection of pretreatment specimens must be completed within 30 days prior to registration to S1117; specimens must be submitted to the site's preferred Clinical Laboratory Improvement Amendments (CLIA)-approved cytogenetics laboratory; reports of the results must be submitted as described; note that cytogenetics are required at other timepoints; NOTE: National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) sites may submit specimens to College of American Pathologists (CAP) or Ontario Laboratory Accreditation (OLA)-approved laboratories providing the lab is licensed to perform fluorescent in situ hybridization (FISH) analysis
- Alliance: Alliance patients must enroll on Cancer and Leukemia Group B (CALGB) 8461, the cytogenetics protocol; CALGB 8461 provides sample procurement and submission instructions to Alliance-approved institutional cytogeneticists; note that cytogenetics are required at other timepoints
- ECOG-ACRIN: Pretreatment cytogenetics must be performed on all patients; collection of pretreatment specimens must be completed within 30 days prior to registration to S1117; specimens must be submitted to the site's preferred CLIA-approved cytogenetics laboratory; karyotypes and reports must be submitted for review to the Mayo Clinic Cytogenetics Laboratory in Rochester; note that cytogenetics testing is required at other timepoints
-
Banking requirements:
- SWOG, Alliance and ECOG-ACRIN (and other sites not affiliated with NCIC CTG): Patients must be offered participation in specimen banking; with patient consent, specimens must be submitted as outlined
- Alliance: (Temporarily Closed 2/28/14): As of February 28, 2014, CALGB 9665 has been temporarily closed, so Alliance patients under consideration for S1117 are NOT to be registered to CALGB 9665 and no specimens for patients enrolled after February 28, 2014 are to be submitted via this ancillary study; these patients should submit specimens per SWOG instructions; patients already enrolled on CALGB 9665 should continue to submit specimens per instructions in CALGB 9665
- NCIC CTG: NCIC CTG patients must be offered participation in specimen submission and banking; with patient consent, specimens must be submitted as outlined
-
All patients or their legally authorized representative must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines
-
As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system
Studijní plán
Jak je studie koncipována?
Detaily designu
- Primární účel: Léčba
- Přidělení: Randomizované
- Intervenční model: Paralelní přiřazení
- Maskování: Žádné (otevřený štítek)
Zbraně a zásahy
Skupina účastníků / Arm |
Intervence / Léčba |
|---|---|
|
Experimentální: Arm I (azacitidine and lenalidomide)
Patients receive azacitidine SC or IV on days 1-7 or days 1-5 and 8-9, and lenalidomide PO QD on days 1-21. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity. |
Correlative studies Given PO
Ostatní jména:
Given SC or IV
Ostatní jména:
|
|
Experimentální: Arm II (azacitidine)
Patients receive azacitidine as in Arm I. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity. |
Correlative studies Given SC or IV
Ostatní jména:
|
|
Experimentální: Arm III (azacitidine and vorinostat)
Patients receive azacitidine as in Arm I and vorinostat PO BID on days 3-9. Courses repeat every 28 days for up to 5 years in the absence of disease progression or unacceptable toxicity. |
Correlative studies Given SC or IV
Ostatní jména:
Given PO
Ostatní jména:
|
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Response Rate (Phase II)
Časové okno: Up to 5 years
|
A response is any of complete hematological remission, partial remission, or hematologic improvement. |
Up to 5 years
|
|
Overall Survival (Phase III)
Časové okno: Up to 5 years
|
OS is calculated for all patients from the date of initial registration to date of death due to any cause. The follow-up for patients last known to be alive is censored at the date of last contact. Stratified Cox regression models will be used to compare OS of the combination arm selected in the Phase II portion of the trial to OS of the single-agent azacitidine arm. |
Up to 5 years
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Relapse-free Survival
Časové okno: Up to 5 years
|
RFS is calculated for patients who have achieved a response. RFS will be measured from the date of response to the date of first documentation of relapse from response (as defined in the primary objective), or death due to any cause. The follow-up for patients last known to be alive and without report of relapse is censored at the date of last contact. RFS will be estimated for each of the three arms using the Kaplan-Meier method. |
Up to 5 years
|
|
Overall Survival
Časové okno: Up to 5 years
|
OS is calculated for all patients from the date of initial registration to date of death due to any cause. The follow- up for patients last known to be alive is censored at the date of last contact. OS will be estimated for each of the three arms using the Kaplan-Meier method. |
Up to 5 years
|
|
Pre-study Cytogenetic Abnormalities
Časové okno: Up to 5 years
|
Cytogenetic risk group is used to identify cytogenetic abnormalities. |
Up to 5 years
|
|
Toxicity Rate
Časové okno: Up to 5 years
|
Adverse events that are possibly, probably or definitely related to study drug are reported. |
Up to 5 years
|
Spolupracovníci a vyšetřovatelé
Sponzor
Vyšetřovatelé
- Vrchní vyšetřovatel: Mikkael A Sekeres, SWOG Cancer Research Network
Publikace a užitečné odkazy
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Aktuální)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Odhadovaný)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
- Patologické procesy
- Novotvary
- Chronické onemocnění
- Atributy nemoci
- Genetické choroby, vrozené
- Novotvary podle histologického typu
- Hematologická onemocnění
- Leukémie, myeloidní
- Myelodysplastická-myeloproliferativní onemocnění
- Nemoci kostní dřeně
- Anémie
- Leukémie
- Anémie, refrakterní
- Vrozené, dědičné a neonatální nemoci a abnormality
- Patologické stavy, příznaky a symptomy
- Hemická a lymfatická onemocnění
- Nedostatek GATA2
- Leukémie, myelomonocytární, chronická
- Myelodysplastické syndromy
- Anémie, refrakterní, s nadměrnými výbuchy
- Organické chemikálie
- Heterocyklické sloučeniny, 1 kruh
- Heterocyklické sloučeniny
- Heterocyklické sloučeniny, 2-prsten
- Heterocyklické sloučeniny, fúzované kroužek
- Nukleové kyseliny, nukleotidy a nukleosidy
- Karboxylové kyseliny
- Hydroxy kyseliny
- Anilides
- Amidy
- Anilinové sloučeniny
- Aminy
- Piperidiny
- Cytidin
- Pyrimidinové nukleosidy
- Pyrimidiny
- Aza sloučeniny
- Nukleosidy
- Ribonukleosidy
- Fthalimidy
- Kyseliny ftalové
- Kyseliny, karbocyklické
- Piperidony
- Isoindoly
- Kyseliny hydroxamové
- Hydroxylaminy
- Lenalidomid
- Vorinostat
- Azacitidin
Další identifikační čísla studie
- NCI-2012-00242
- U10CA032102 (Grant/smlouva NIH USA)
- U10CA180888 (Grant/smlouva NIH USA)
- NCI-2012-00242 (Identifikátor registru: CTRP (Clinical Trial Reporting Program))
- CDR0000723909
- SWOG-S1117
- S1117 (Jiný identifikátor: CTEP)
- S1117 (Jiný identifikátor: SWOG)
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .